Evidence map›Paper›PMID 39456704›Full record

SynthesisInternational journal of molecular sciences2024

Effect of

Kabelo Mokgalaboni, Wendy N Phoswa, Tyson T Mokgalabone, Sanele Dlamini, Ashwell R Ndhlala, Perpetua Modjadji, Sogolo L Lebelo

Abstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Investigating the Impact ofPlants (Basel, Switzerland) · 2026
    Review
  4. Antioxidants (Basel, Switzerland) · 2025
    Article
  5. Synergistic Effect of Banaba Leaf Extract and Policosanol (RaydelPharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kabelo MokgalaboniDepartment of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Florida Campus, Roodepoort 1710, South Africa.ORCID 0000-0002-3224-7433
Wendy N PhoswaDepartment of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Florida Campus, Roodepoort 1710, South Africa.ORCID 0000-0002-7769-4528
Tyson T MokgalaboneGreen Biotechnologies Research Centre of Excellence, Department of Plant Production, Soil Science and Agricultural Engineering, University of Limpopo, Private Bag X1106, Sovenga 0727, South Africa.ORCID 0000-0002-2514-2123
Sanele DlaminiSchool of Chemicals and Physical Sciences, Faculty of Agriculture and Natural Science, University of Mpumalanga, Mbombela 1200, South Africa.
Ashwell R NdhlalaDepartment of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Florida Campus, Roodepoort 1710, South Africa.
Perpetua ModjadjiDepartment of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Florida Campus, Roodepoort 1710, South Africa.ORCID 0000-0002-8339-9875
Sogolo L LebeloDepartment of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Florida Campus, Roodepoort 1710, South Africa.

Funding

NRF Special Transformation Awards (NRF Awards) NSTA231114163486Research Development Grants for nGAP Scholars (NGAP23022780506), and Black Academics Advancement Programme PhD Track NFSG230512105121
6 · The paper itself

Abstract

The global prevalence of cardiovascular diseases (CVDs), including dyslipidemia and atherosclerosis, is rising. While pharmacological treatments for dyslipidemia and associated CVDs exist, not all individuals can afford them, and those who do often experience adverse side effects. Preclinical studies have indicated the potential benefits of

Indexed as

AbelmoschusDyslipidemiasAnimalsHumansPhytochemicalsTriglyceridesPhytochemicalsTriglyceridesAbelmoschus esculentusdyslipidemiaHisbiscus esculentushyperglycemiaokraprediabetestype 2 diabetes

Identifiers

PMID39456704
PMCPMC11507881

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.